Topical imipramine for skin UVB light sensitivity
Part of Skin clinical trials.
This Phase 1 study tests whether a cream called imipramine can reduce tiny UVB-triggered skin “microvesicles” in people who are sensitive to sunlight. The goal is to see if the cream is safe and may lessen harmful skin reactions from UVB exposure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 50 and can sign consent
- You identify yourself as having light/sun sensitivity
- You can reliably get to the study site and appointments (stable transportation)
- You can list your medicines and avoid known light-sensitizing drugs
- You cannot be pregnant, trying to conceive, or breastfeeding if you’re female
- You cannot use or have used tanning beds or UVB/photodynamic treatments recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether applying imipramine cream to the skin affects pain and effectiveness when combined with a light-based skin treatment (photodynamic therapy). It’s mainly looking at safety and early signs of benefit for people with certain sun-damaged skin areas.
This trial tests whether adding a cream called imipramine to standard photodynamic therapy (light treatment) can reduce the immune suppression that sometimes happens after the therapy. It may help veterans with sun-damaged skin on their forearms or face.
This study tests if creams containing two antidepressants (imipramine and amitriptyline) can reduce skin redness caused by UV light in people with rosacea. It compares how the creams affect redness to see if they could be a new treatment option.
This study tests whether a common antidepressant called amitriptyline, taken by mouth, can reduce harmful particles released after a small controlled burn injury to your skin. Researchers hope this might help prevent excessive scarring and aid healing.
This trial tests if a cream containing amitriptyline can block a substance released by the skin after injury. It aims to learn more about how wounds heal and prevent scarring.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
Hear when a new Photosensitivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.